Published in Neuropharmacology on January 01, 1984
Phenotypic alteration of a human BK (hSlo) channel by hSlobeta subunit coexpression: changes in blocker sensitivity, activation/relaxation and inactivation kinetics, and protein kinase A modulation. J Neurosci (1996) 1.81
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med (2001) 1.43
Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits. Nat Neurosci (1998) 1.42
Effects of channel modulators on cloned large-conductance calcium-activated potassium channels. Mol Pharmacol (1996) 1.38
Serotoninergic mechanism of clonidine and apomorphine interaction. Pol J Pharmacol Pharm (1975) 1.07
Time course of improvement under antidepressant treatment: a survival-analytical approach. Eur Neuropsychopharmacol (1993) 1.04
Drugs affecting dopamine neurons and yawning behavior. Pharmacol Biochem Behav (1977) 1.01
Correlations between different measures of antiserotonin activity of drugs. Study with neuroleptics and serotonin receptor blockers. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.98
Preferential deamination of dopamine by an A type monoamine oxidase in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.97
Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy. Pharmacol Biochem Behav (1975) 0.94
Desipramine induces yawning behaviour in rats. Neuropharmacology (1986) 0.93
Interaction of beta-adrenoceptor agonists with the serotonergic system in rat brain. A behavioral study using the L-5-HTP syndrome. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.93
The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.93
Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. Eur J Pharmacol (1987) 0.92
Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses. Pharmacopsychiatry (1996) 0.90
Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and postsynaptic central noradrenergic receptor selectivity of alpha-adrenolytic drugs. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.87
Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenethylamine and apomorphine. J Pharm Pharmacol (1976) 0.84
Novelty-oriented behavior in the rat after selective damage of locus coeruleus projections by DSP-4, a new noradrenergic neurotoxin. Pharmacol Biochem Behav (1984) 0.82
Antidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774), in the mouse behavioral despair test. Eur J Pharmacol (1990) 0.81
Age-dependence of effects of A1 adenosine receptor antagonism in rat hippocampal slices. J Neurophysiol (1992) 0.81
Some central pharmacological effects of the calcium channel antagonist flunarizine. J Neural Transm Gen Sect (1991) 0.81
Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement. Pharmacopsychiatry (1999) 0.81
Deprivation of REM sleep in the rat and the opioid peptides beta-endorphin and dynorphin. Neurosci Lett (1986) 0.81
Neuroanatomical, neuropharmacological and neurobiochemical target systems for antipsychotic activity of neuroleptics. Pharmacopsychiatry (1986) 0.80
Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs. Pharmacopsychiatry (1991) 0.80
Effect of nifedipine on the shuttlebox escape deficit induced by inescapable shock in the rat. Eur J Pharmacol (1988) 0.80
Dihydropyridine calcium channel antagonists as antidepressant drugs in mice and rats. Neuropharmacology (1989) 0.80
[Pharmacological research on maprotiline a new drug with antidepressive effects]. Boll Chim Farm (1973) 0.80
Neophobia in spontaneous hypertensive (SHR) and normotensive control (WKY) rats. Behav Neural Biol (1985) 0.80
Mianserin, danitracen and amitriptyline withdrawal increases the behavioural responses of rats to L-5-HTP. J Pharm Pharmacol (1979) 0.79
Hypotheses concerning the mechanism of action of antidepressant drugs. Rev Physiol Biochem Pharmacol (1984) 0.79
Chronic treatment with antidepressant drugs: potentiation of apomorphine-induced aggressive behaviour in rats. Neurosci Lett (1979) 0.79
Assessment of sexual dysfunction in depressed patients and reporting attitudes in routine daily practice: Results of the postmarketing observational studies with moclobemide, a reversible MAO-A inhibitor. Int J Psychiatry Clin Pract (1999) 0.79
Increase in beta- and alpha 1-adrenoceptor binding sites in the rat brain and in the alpha 1-adrenoceptor functional sensitivity after the DSP-4-induced noradrenergic denervation. Pharmacol Biochem Behav (1986) 0.78
REM sleep deprivation changes behavioral response to catecholaminergic and serotonergic receptor activation in rats. Pharmacol Biochem Behav (1981) 0.78
Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine. Pharmacopsychiatry (1991) 0.78
Effect of chronic administration of antidepressant drugs on the noradrenaline disappearance induced by FLA-63 in the rat brain. Pol J Pharmacol Pharm (1979) 0.78
Clonidine and a beta-agonists induce hyperthermia in rats at high ambient temperature. J Neural Transm (1985) 0.78
Suppressant effect of REM sleep deprivation on neophobia in normal rats and in rats with selective DSP-4 induced damage of locus coeruleus neurons. Pharmacol Biochem Behav (1985) 0.78
The effect of repeated administration of antidepressant drugs on the responsiveness of rats to catecholamine agonists. J Neural Transm (1979) 0.78
Onset of action under antidepressant treatment. Eur Psychiatry (1997) 0.78
Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 4. Toxicity and general pharmacology of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexy l-2-imino- imidazolidine (CGP 11 112). Arzneimittelforschung (1984) 0.78
Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients. J Neural Transm Suppl (1989) 0.78
Adaptive and differential changes on beta- and alpha 2-adrenoreceptors mediated hyperthermia after chronic treatment with antidepressant drugs in the rat kept at high ambient temperature. J Neural Transm (1985) 0.78
Antidepressants and drug-metabolizing enzymes--expert group report. Acta Psychiatr Scand (1996) 0.78
Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin. Psychopharmacology (Berl) (1983) 0.78
Some behavioral effects of repeated administration of calcium channel antagonists. Pharmacol Biochem Behav (1990) 0.77
The effect of L-DOPA and L-5-hydroxytryptophan on the pentetrazole seizures in rats after lesions of the median raphe nucleus and substantia nigra. Pol J Pharmacol Pharm (1980) 0.77
Different pharmacokinetic and pharmacological effects following acute and chronic treatment with imipramine. J Neural Transm (1982) 0.77
Inhibitory effects of propranolol and oxprenolol on excitation induced by a MAO inhibitor and reserpine in the mouse. Neuropharmacology (1976) 0.77
The effect of L-DOPA on brain catecholamines and motility in rats. Psychopharmacologia (1971) 0.77
Rapid-eye-movement sleep deprivation inhibits clonidine-induced sedation in rats. Eur J Pharmacol (1981) 0.76
Synthesis and biological evaluation of an iodinated iberiotoxin analogue, [mono-iodo-Tyr5, Phe36]-iberiotoxin. Int J Pept Protein Res (1996) 0.76
Evidence for increased apomorphine-sensitive dopaminergic effects after acute treatment with morphine. Psychopharmacology (Berl) (1977) 0.76
Rapid-eye-movement sleep deprivation decreases the density of 3H-dihydroalprenolol and 3H-imipramine binding sites in the rat cerebral cortex. Eur J Pharmacol (1980) 0.76
Effects of REM sleep deprivation on central alpha 1- and beta-adrenoceptors in rat brain. Pharmacol Biochem Behav (1986) 0.76
Pharmaco-EEG profile of levoprotiline: second example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs. Pharmacopsychiatry (1991) 0.76
Delayed onset of action of antidepressant drugs? Survey of recent results. Eur Psychiatry (1997) 0.75
A role for sigma binding in the antipsychotic profile of BMY 14802? NIDA Res Monogr (1993) 0.75
The development and the extinction of hyperthermia induced by conditioned avoidance behavior in rats. J Exp Anal Behav (1970) 0.75
Moclobemide versus fluoxetine for double depression: a randomized double-blind study. J Psychiatr Res (1997) 0.75
Repeated treatment with clenbuterol produces desensitization of rat brain beta- and alpha 2-adrenoceptors without changes of alpha 1-adrenoceptors. Eur J Pharmacol (1986) 0.75
Facilitated shock-induced aggression after chronic treatment with antidepressant drugs in the rat. Pharmacol Biochem Behav (1981) 0.75
Age-dependent day/night variations of alpha 1- and beta-adrenoceptors in the rat cerebral cortex. Physiol Behav (1986) 0.75
Chronic treatment with antidepressants: protentiation of clonidine-induced aggression in mice via noradrenergic mechanism. J Neural Transm (1981) 0.75
Influence of salbutamol and other beta-agonists on hypothermia induced by clonidine, apomorphine and reserpine in mice. J Neural Transm (1981) 0.75
Effect of yohimbine and its diastereoisomers on clonidine-induced depression of exploration in the rat. Eur J Pharmacol (1982) 0.75
The effects of acute and repeated treatment with salbutamol, a beta-adrenoceptor agonist, on clonidine-induced hypoactivity in rats. J Neural Transm (1982) 0.75
[Pharmacological studies on the effect of neuroleptics in animals after single and repeated application]. Arzneimittelforschung (1968) 0.75
Altered hindlimb extension in the rat after DSP-4: a useful marker of central noradrenergic depletion. Eur J Pharmacol (1983) 0.75
Central action of Craviten (M-71). Pol J Pharmacol Pharm (1981) 0.75
Molecular size of alpha 1- and beta-adrenoceptors in rat brain cortex as determined by a radiation inactivation method. Eur J Pharmacol (1986) 0.75
Modulation of dopamine-mediated behavioural responses by antidepressants: effects of single and repeated treatment. Eur J Pharmacol (1979) 0.75
Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptake. Arzneimittelforschung (1986) 0.75
The influence of beta-agonists on normal and clonidine-decelerated noradrenaline turnover in the rat brain. Pol J Pharmacol Pharm (1986) 0.75
Effects of chronic administration of antidepressant drugs on aggressive behavior induced by clonidine in mice. Pharmacol Biochem Behav (1980) 0.75
Stereospecificity of behavioural and biochemical responses to oxaprotiline--a new antidepressant. Adv Biochem Psychopharmacol (1982) 0.75
Facilitation of shock-induced fighting in the rat after DSP-4, a selective noradrenergic neurotoxin. Pharmacol Biochem Behav (1983) 0.75
Effect of beta-adrenoceptor agonists on apomorphine-induced turning in rats. J Neural Transm (1985) 0.75
New pharmacological findings in depression. Psychopathology (1986) 0.75
Progress in the psychopharmacology of antidepressants: selective uptake and MAO-inhibitors. Schweiz Arch Neurol Psychiatr (1986) 0.75
High-performance liquid chromatographic method for the determination of sudexanox as the free acid in plasma. J Chromatogr (1986) 0.75
Chronic treatment with some atypical antidepressants increases the brain level of 3-methoxy-4-hydroxyphenylglycol (MHPG) in rats. Psychopharmacology (Berl) (1981) 0.75
Simple behavioral measures of central alpha-adrenoceptor blocking activity of drugs. Pol J Pharmacol Pharm (1985) 0.75
Characterization of a new, short-acting and specific inhibitor of type A monoamine oxidase. Mod Probl Pharmacopsychiatry (1983) 0.75
[Psychobiology of fear]. Schweiz Rundsch Med Prax (1992) 0.75
Non-response to antidepressants: risk factors and therapeutic possibilities. Pharmacopsychiatry (1988) 0.75
Interaction between beta-adrenoceptor agonists and alpha 1-adrenergic system. A behavioral study with the clonidine-induced aggression test. Pol J Pharmacol Pharm (1987) 0.75
The effects of antidepressants on aggressiveness induced by social deprivation in mice. Pharmacol Biochem Behav (1981) 0.75
Are beta- and alpha 2-adrenoceptors co-regulated during their stimulation? Behavioral studies. Pol J Pharmacol Pharm (1987) 0.75
The effects of single and repeated doses of maprotiline, oxaprotiline and its enantiomers on foot-shock induced fighting in rats. Pharmacol Biochem Behav (1983) 0.75
The importance of timing for the action of alpha 1- or beta-agonists: possible relationship with the density of [3H]prazosin and [3H]dihydroalprenolol binding sites. Eur J Pharmacol (1985) 0.75
Septo-hippocampal system: target for substituted benzamides. Eur J Pharmacol (1982) 0.75